Amedeo Smart

Free Medical Literature Service


 

Amedeo

Schizophrenia

  Free Subscription

Articles published in
PLoS One
    January 2024
  1. PEREZ-ROMERO N, Campos-Jara C, Pesce C, Araya Sierralta S, et al
    Effects of physical exercise on executive functions of individuals with schizophrenia spectrum disorders: Protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0296273.
    >> Share

  2. CLEMMENSEN L, Lund CN, Andresen BS, Midtgaard J, et al
    Study protocol for RUFUS-A randomized mixed methods pilot clinical trial investigating the relevance and feasibility of rumination-focused cognitive behavioral therapy in the treatment of patients with emergent psychosis spectrum disorders.
    PLoS One. 2024;19:e0297118.
    >> Share

  3. JAKA S, Singh S, Vashist S, Pokhrel S, et al
    Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study.
    PLoS One. 2024;19:e0296870.
    >> Share

  4. ROSADO D, Intriago B, Loor E, Alcivar F, et al
    Associations between Toxoplasma gondii seropositivity and psychopathological manifestations in schizophrenic patients: A single-center study from Ecuador.
    PLoS One. 2024;19:e0297523.
    >> Share

  5. FEIJS HME, van Aken L, van der Veld WM, van der Heijden PT, et al
    No relations between executive functions and dimensional models of psychopathology or is time the missing link?
    PLoS One. 2024;19:e0288386.
    >> Share


  6. Expression of Concern: Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location.
    PLoS One. 2024;19:e0301152.
    >> Share

    January 2023
  7. LI S, Otsuka I, Tanifuji T, Okazaki S, et al
    Ribosomal DNA gene copies are increased in blood and brain of Japanese schizophrenia patients.
    PLoS One. 2023;18:e0280694.
    >> Share

  8. BYRNE MK, Easpaig BNG, Gray R, Creek R, et al
    Behavioural activation for depressive symptoms in young people with emerging or early psychosis: A pilot study protocol.
    PLoS One. 2023;18:e0280559.
    >> Share

  9. LONGARDNER K, Wright BA, Alakkas A, You H, et al
    Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis.
    PLoS One. 2023;18:e0278262.
    >> Share

  10. COHEN LS, Vanderkruik R, Arakelian M, Church TR, et al
    Establishment of the MGH Postpartum Psychosis Project: MGHP3.
    PLoS One. 2023;18:e0281133.
    >> Share

  11. MIDDLETON CURRAN L, Sheridan Rains L, Taylor J, Morant N, et al
    Acceptability and feasibility of using contingency management for cannabis reduction in specialist mental health services for psychosis: A qualitative study of staff views.
    PLoS One. 2023;18:e0281368.
    >> Share

  12. HANCOCK F, Rosas FE, McCutcheon RA, Cabral J, et al
    Metastability as a candidate neuromechanistic biomarker of schizophrenia pathology.
    PLoS One. 2023;18:e0282707.
    >> Share

  13. FEI X, Wang S, Li J, Wang J, et al
    The efficacy and safety of sodium nitroprusside in the treatment of schizophrenia: Protocol for an updated systematic review and meta-analysis.
    PLoS One. 2023;18:e0283185.
    >> Share

  14. XAVIER RM, Shanavas Y, Britt BM, George WT, et al
    Influences of race and clinical variables on psychiatric genetic research participation: Results from a schizophrenia sample.
    PLoS One. 2023;18:e0284356.
    >> Share

  15. XU F, Xian Z
    Study investigating executive function in schizophrenia patients and their unaffected siblings.
    PLoS One. 2023;18:e0285034.
    >> Share

  16. RAJAGOPALAN A, Lim KWK, Tan XW, Martin D, et al
    Predictors of cognitive changes in patients with schizophrenia undergoing electroconvulsive therapy.
    PLoS One. 2023;18:e0284579.
    >> Share

  17. MIZUTANI R, Saiga R, Yamamoto Y, Uesugi M, et al
    Structural aging of human neurons is opposite of the changes in schizophrenia.
    PLoS One. 2023;18:e0287646.
    >> Share

  18. ROTENBERG M, Gozdyra P, Anderson KK, Kurdyak P, et al
    The role of geography and distance on physician follow-up after a first hospitalization with a diagnosis of a schizophrenia spectrum disorder: A retrospective population-based cohort study in Ontario, Canada.
    PLoS One. 2023;18:e0287334.
    >> Share

  19. SASAKI J, Muranaka S, Arahata K, Sato A, et al
    Developing and validating the Japanese version of the Referential Thinking Scale: A cross-sectional study.
    PLoS One. 2023;18:e0283416.
    >> Share

  20. GUNDOGMUS AG, Gerretsen P, Song J, Erdi Akdag F, et al
    Insight in schizophrenia is associated with psychoeducation and social support: Testing a new more comprehensive insight tool in Turkish schizophrenia patients.
    PLoS One. 2023;18:e0288177.
    >> Share

  21. ISLAM MK, Islam MR, Rahman MH, Islam MZ, et al
    Integrated bioinformatics and statistical approach to identify the cmmon mlecular mchanisms of oesity that are linked to the development of two psychiatric disorders: Schizophrenia and major depressive disorder.
    PLoS One. 2023;18:e0276820.
    >> Share

  22. CANESSA N, Iozzino L, Andreose S, Castelletti L, et al
    RISK aversion in Italian forensic and non-forensic patients with schizophrenia spectrum disorders.
    PLoS One. 2023;18:e0289152.
    >> Share

  23. MONTAZERI M, Moradi E, Moosazadeh M, Hosseini SH, et al
    Relationship between Toxoplasma gondii infection and psychiatric disorders in Iran: A systematic review with meta-analysis.
    PLoS One. 2023;18:e0284954.
    >> Share

  24. TAMENE FB, Sema FD, Sendekie AK
    Antipsychotic polypharmacy and associated factors among patients with schizophrenia: Multicenter cross-sectional study in Northwest Ethiopia.
    PLoS One. 2023;18:e0290037.
    >> Share

  25. RANDHAWA A, Kuhn S, Schottle D, Moritz S, et al
    The effects of assessing character strengths vs. psychopathology on mood, hope, perceived stigma and cognitive performance in individuals with psychosis.
    PLoS One. 2023;18:e0289872.
    >> Share

  26. CHAVES MF, Rodrigues C, Ribeiro S, Mota NB, et al
    Grammatical impairment in schizophrenia: An exploratory study of the pronominal and sentential domains.
    PLoS One. 2023;18:e0291446.
    >> Share

  27. AGARWAL SM, Dissanayake J, Agid O, Bowie C, et al
    Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol.
    PLoS One. 2023;18:e0288354.
    >> Share

  28. MARTZOUKOU M, Papadopoulos D, Kosmidis MH
    Syntactic and affective prosody recognition: Schizophrenia vs. Autism spectrum disorders.
    PLoS One. 2023;18:e0292325.
    >> Share

  29. JUCHNOWICZ D, Dzikowski M, Rog J, Waszkiewicz N, et al
    The usefulness of a complete blood count in the prediction of the first episode of schizophrenia diagnosis and its relationship with oxidative stress.
    PLoS One. 2023;18:e0292756.
    >> Share

  30. LYLES S, Khan Z, Qureshi O, Shaikh M, et al
    A systematic review of the effectiveness and implementation readiness of psychosocial interventions for psychosis in South Asia.
    PLoS One. 2023;18:e0283411.
    >> Share

  31. CLEMENTI L, Arnone E, Santambrogio MD, Franceschetti S, et al
    Anatomically compliant modes of variations: New tools for brain connectivity.
    PLoS One. 2023;18:e0292450.
    >> Share

  32. ABDIN E, Seet V, Jeyagurunathan A, Tan SC, et al
    Validation of the 12-item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore.
    PLoS One. 2023;18:e0294908.
    >> Share

  33. LAWRIE S, Hanlon C, Manda-Taylor L, Knapp M, et al
    Psychosis Recovery Orientation in Malawi by Improving Services and Engagement (PROMISE) protocol.
    PLoS One. 2023;18:e0293370.
    >> Share

    January 2022
  34. ADJORLOLO S, Mensah G, Badzi CD
    Psychosis risk among pregnant women in Ghana.
    PLoS One. 2022;17:e0263011.
    >> Share

  35. ABED-ESFAHANI P, Darwin BC, Howard D, Wang N, et al
    Evaluation of deep convolutional neural networks for in situ hybridization gene expression image representation.
    PLoS One. 2022;17:e0262717.
    >> Share

  36. DHUNGANA S, Tulachan P, Chapagai M, Pant SB, et al
    Internalized stigma in patients with schizophrenia: A hospital-based cross-sectional study from Nepal.
    PLoS One. 2022;17:e0264466.
    >> Share

  37. OKAZAKI S, Boku S, Watanabe Y, Otsuka I, et al
    Polymorphisms in the hypoxia inducible factor binding site of the macrophage migration inhibitory factor gene promoter in schizophrenia.
    PLoS One. 2022;17:e0265738.
    >> Share

  38. JIANG Z, Luskus M, Seyedi S, Griner EL, et al
    Utilizing computer vision for facial behavior analysis in schizophrenia studies: A systematic review.
    PLoS One. 2022;17:e0266828.
    >> Share

  39. SARIS IMJ, Aghajani M, Jongs N, Reus LM, et al
    Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer's disease patients.
    PLoS One. 2022;17:e0263769.
    >> Share

  40. LIAN L, Kim DD, Procyshyn RM, Cazares D, et al
    Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review.
    PLoS One. 2022;17:e0267808.
    >> Share

  41. TOYAMA M, Takasaki Y, Branko A, Kimura H, et al
    Exome sequencing of Japanese schizophrenia multiplex families supports the involvement of calcium ion channels.
    PLoS One. 2022;17:e0268321.
    >> Share

  42. ALGUMAEI AH, Algunaid RF, Rushdi MA, Yassine IA, et al
    Feature and decision-level fusion for schizophrenia detection based on resting-state fMRI data.
    PLoS One. 2022;17:e0265300.
    >> Share

  43. FAULKNER SM, Drake RJ, Ogden M, Gardani M, et al
    A mixed methods expert opinion study on the optimal content and format for an occupational therapy intervention to improve sleep in schizophrenia spectrum disorders.
    PLoS One. 2022;17:e0269453.
    >> Share

  44. ERSHOVA ES, Shmarina GV, Martynov AV, Zakharova NV, et al
    NADPH-oxidase 4 gene over-expression in peripheral blood lymphocytes of the schizophrenia patients.
    PLoS One. 2022;17:e0269130.
    >> Share

  45. ADEME M, Kebede T, Teferra S, Alemayehu M, et al
    Is latent Toxoplasma gondii infection associated with the occurrence of schizophrenia? A case-control study.
    PLoS One. 2022;17:e0270377.
    >> Share

  46. BARBIC D, Whyte M, Sidhu G, Luongo A, et al
    One-year mortality of emergency department patients with substance-induced psychosis.
    PLoS One. 2022;17:e0270307.
    >> Share

  47. CHIEN TY, Chern JS, Wang SP, Yang Y, et al
    Effects of multitask training on cognition and motor control in people with schizophrenia spectrum disorders.
    PLoS One. 2022;17:e0264745.
    >> Share

  48. YOSHIKAWA A, Kushima I, Miyashita M, Suzuki K, et al
    Exonic deletions in IMMP2L in schizophrenia with enhanced glycation stress subtype.
    PLoS One. 2022;17:e0270506.
    >> Share

  49. AKENA D, Semeere A, Kadama P, Mwesiga EK, et al
    Feasibility of conducting a pilot randomized control trial of a psycho-education intervention in patients with a first episode psychosis in Uganda-A study protocol.
    PLoS One. 2022;17:e0268493.
    >> Share

  50. GARGANO G, Caletti E, Perlini C, Turtulici N, et al
    Language production impairments in patients with a first episode of psychosis.
    PLoS One. 2022;17:e0272873.
    >> Share

  51. WYNN JK, McCleery A, Novacek DM, Reavis EA, et al
    The impact of the COVID-19 pandemic on mental health and functional outcomes in Veterans with psychosis or recent homelessness: A 15-month longitudinal study.
    PLoS One. 2022;17:e0273579.
    >> Share

  52. KHATTAK MI, Dikomitis L, Khan MF, Haq MU, et al
    Patients' and healthcare professionals' perspectives on a community-based intervention for schizophrenia in Pakistan: A focus group study.
    PLoS One. 2022;17:e0273286.
    >> Share

  53. KADRA-SCALZO G, Fonseca de Freitas D, Agbedjro D, Francis E, et al
    A predictor model of treatment resistance in schizophrenia using data from electronic health records.
    PLoS One. 2022;17:e0274864.
    >> Share

  54. AL-HAKEIM HK, Al-Musawi AF, Al-Mulla A, Al-Dujaili AH, et al
    The interleukin-6/interleukin-23/T helper 17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: A precision nomothetic psychiatry analysis.
    PLoS One. 2022;17:e0275839.
    >> Share

  55. RAMOS-MASTACHE D, Mondragon-Maya A, Liemburg EJ, Enriquez-Geppert S, et al
    Understanding the relationship between apathy, cognition and functional outcome in schizophrenia: The significance of an ecological assessment.
    PLoS One. 2022;17:e0277047.
    >> Share

  56. JONES CJ, Hazell CM, Hayward M, Pandey A, et al
    Caring for Carers (C4C): Results from a feasibility randomised controlled trial of positive written disclosure for older adult carers of people with psychosis.
    PLoS One. 2022;17:e0277196.
    >> Share

  57. RAZZAK RA, Jahrami H, Husni M, Ali ME, et al
    Perceptual visual dependence for spatial orientation in patients with schizophrenia.
    PLoS One. 2022;17:e0278718.
    >> Share

  58. AL-NEMA M, Gaurav A, Lee MT, Okechukwu P, et al
    Evaluation of the acute oral toxicity and antipsychotic activity of a dual inhibitor of PDE1B and PDE10A in rat model of schizophrenia.
    PLoS One. 2022;17:e0278216.
    >> Share

  59. JOHNSON T, Saatci D, Handunnetthi L
    Maternal immune activation induces methylation changes in schizophrenia genes.
    PLoS One. 2022;17:e0278155.
    >> Share

  60. MATHIS WS, Ferrara M, Burke S, Hyun E, et al
    Granular analysis of pathways to care and durations of untreated psychosis: A marginal delay model.
    PLoS One. 2022;17:e0270234.
    >> Share

  61. SOLER-VIDAL J, Fuentes-Claramonte P, Salgado-Pineda P, Ramiro N, et al
    Brain correlates of speech perception in schizophrenia patients with and without auditory hallucinations.
    PLoS One. 2022;17:e0276975.
    >> Share

  62. VAN DER STOUWE ECD, de Vries B, Steenhuis LA, Waarheid CO, et al
    BEATVIC, a body-oriented resilience therapy for individuals with psychosis: Short term results of a multi-center RCT.
    PLoS One. 2022;17:e0279185.
    >> Share

    January 2021
  63. HINOJOSA-MARQUES L, Monsonet M, Kwapil TR, Barrantes-Vidal N, et al
    The impact of family environment on self-esteem and symptoms in early psychosis.
    PLoS One. 2021;16:e0249721.
    >> Share

  64. MAKI S, Nagai K, Ando S, Tamakoshi K, et al
    Structure and predictors of in-hospital nursing care leading to reduction in early readmission among patients with schizophrenia in Japan: A cross-sectional study.
    PLoS One. 2021;16:e0250771.
    >> Share

  65. WENG S, Wang B, Li M, Chao S, et al
    Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
    PLoS One. 2021;16:e0249997.
    >> Share

  66. HAYASHI N, Igarashi Y, Harima H
    Delusion progression process from the perspective of patients with psychoses: A descriptive study based on the primary delusion concept of Karl Jaspers.
    PLoS One. 2021;16:e0250766.
    >> Share

  67. ROSEN DL, Travers D
    Emergency department visits among patients transported by law enforcement officers.
    PLoS One. 2021;16:e0244679.
    >> Share

  68. KIM K, Duc NT, Choi M, Lee B, et al
    EEG microstate features for schizophrenia classification.
    PLoS One. 2021;16:e0251842.
    >> Share

  69. KRONBICHLER L, Stelzig-Scholer R, Lenger M, Weber S, et al
    Preserved intention understanding during moral judgments in schizophrenia.
    PLoS One. 2021;16:e0251180.
    >> Share

  70. LINCOLN SH, Johnson T, Kim S, Edenbaum E, et al
    Psychosis proneness, loneliness, and hallucinations in nonclinical individuals.
    PLoS One. 2021;16:e0251753.
    >> Share

  71. KOBORI A, Miyashita M, Miyano Y, Suzuki K, et al
    Advanced glycation end products and cognitive impairment in schizophrenia.
    PLoS One. 2021;16:e0251283.
    >> Share

  72. KURUKGY JL, Bourgin J, Benoit JP, Guessoum SB, et al
    Implementing organicity investigations in early psychosis: Spreading expertise.
    PLoS One. 2021;16:e0252610.
    >> Share

  73. NOROVSAMBUU O, Tsend-Ayush A, Lkhagvasuren N, Jav S, et al
    Main characteristics of dermatoglypics associated with schizophrenia and its clinical subtypes.
    PLoS One. 2021;16:e0252831.
    >> Share

  74. SCHILLING TM, Bossert M, Konig M, Wirtz G, et al
    Acute effects of a single dose of 2 mA of anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex on executive functions in patients with schizophrenia-A randomized controlled trial.
    PLoS One. 2021;16:e0254695.
    >> Share

  75. HUCKLE C, Lemmel F, Johnson S
    Experiences of friendships of young people with first-episode psychosis: A qualitative study.
    PLoS One. 2021;16:e0255469.
    >> Share

  76. SHOR O, Glik A, Yaniv-Rosenfeld A, Valevski A, et al
    EEG p-adic quantum potential accurately identifies depression, schizophrenia and cognitive decline.
    PLoS One. 2021;16:e0255529.
    >> Share

  77. JUNG YS, Kim YE, Go DS, Yoon SJ, et al
    The prevalence, incidence, and admission rate of diagnosed schizophrenia spectrum disorders in Korea, 2008-2017: A nationwide population-based study using claims big data analysis.
    PLoS One. 2021;16:e0256221.
    >> Share

  78. SHIMIZU J, Kuwata H, Kuwata K
    Differences in fractal patterns and characteristic periodicities between word salads and normal sentences: Interference of meaning and sound.
    PLoS One. 2021;16:e0247133.
    >> Share

  79. DUTRA-TAVARES AC, Manhaes AC, Semeao KA, Maia JG, et al
    Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model.
    PLoS One. 2021;16:e0257986.
    >> Share

  80. MARTIN J, Asjadi K, Hubbard L, Kendall K, et al
    Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression.
    PLoS One. 2021;16:e0248254.
    >> Share

  81. DOYEN S, Taylor H, Nicholas P, Crawford L, et al
    Hollow-tree super: A directional and scalable approach for feature importance in boosted tree models.
    PLoS One. 2021;16:e0258658.
    >> Share

  82. DESALEGN D, Abdu Z, Hajure M
    Prevalence of tobacco dependence and associated factors among patients with schizophrenia attending their treatments at southwest Ethiopia; hospital-based cross-sectional study.
    PLoS One. 2021;16:e0261154.
    >> Share

  83. WOLDEKIDAN NA, Mohammed AS, Degu A, Tadiwos Y, et al
    Prevalence of metabolic syndrome and associated factors among psychiatric patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
    PLoS One. 2021;16:e0256195.
    >> Share

  84. SAKURAI K, Itou T, Morita M, Kasahara E, et al
    Effects of Importin alpha1/KPNA1 deletion and adolescent social isolation stress on psychiatric disorder-associated behaviors in mice.
    PLoS One. 2021;16:e0258364.
    >> Share

  85. ZANDER-SCHELLENBERG T, Kuhn SAK, Moller J, Meyer AH, et al
    Is intuition allied with jumping to conclusions in decision-making? An intensive longitudinal study in patients with delusions and in non-clinical individuals.
    PLoS One. 2021;16:e0261296.
    >> Share

  86. LEE GS, Zhang J, Wu Y, Zhou Y, et al
    14-3-3 proteins promote synaptic localization of N-methyl d-aspartate receptors (NMDARs) in mouse hippocampal and cortical neurons.
    PLoS One. 2021;16:e0261791.
    >> Share

  87. HAYAKAWA T, Terahara M, Fujito NT, Matsunaga T, et al
    Lower promoter activity of the ST8SIA2 gene has been favored in evolving human collective brains.
    PLoS One. 2021;16:e0259897.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016